Renal Transplant and Its Outcomes: Single-Center Experience From India.

OBJECTIVES: Improvements in early graft survival and long-term graft function have made kidney transplant a more cost-effective alternative to dialysis. We aimed to assess renal transplant outcomes over a 9-month follow-up of recipients in a cost-limited setting (a tertiary care center in India). MATERIALS AND METHODS: Included patients in this prospective observational study were those who underwent renal transplant from July 2016 to February 2017 (8 months) and followed for 9 months. RESULTS: Of 122 included patients, 20 (16.4%) were women and 102 (83.6%) were men (mean age 35.61 ± 10.64 y), with 92 (75.4%) from a lower socioeconomic status. Kidneys were from first-degree relatives for 52 patients (42.6%), from spousal donors for 34 (27.9%), from deceased donors for 24 (19.7%), and from second/third degree relative donors for 12 (9.8%). All patients underwent only complementdependent cytotoxicity crossmatch due to financial constraints. Fifty patients (41%) had history of packed red blood cell transfusion. Induction was thymoglobulin in 60 patients (49.2%), basiliximab in 8 (6.6%), and no induction in 54 (44.3%). Forty patients (30.1%) underwent biopsy for graft dysfunction, and 32 (26.2%) had graft rejection: 18 (14.8%) with antibodymediated rejection, 5 (4.1%) with T-cell-mediated rejection, and 9 (7.4%) with both. Opportunistic infections were shown in 24.5% of patients, including primarily cytomegalovirus (10.7%), tuberculosis (5.7%), and aspergillosis (3.3%). Twenty-nine patients (24%) had new-onset diabetes posttransplant. At end of follow-up, 93 patients (76.2%) had normal graft function, 21 (17.2%) had chronic graft dysfunction, 3 (2.4%) had graft loss, and 5 (4.1%) died. History of blood transfusion (P = .001) predicted the occurrence of antibody-mediated rejection, and induction used showed trend toward prediction (P = .083). CONCLUSIONS: With high rejection rates, it would be prudent to include proper immunologic testing, even in cost-limited settings, pretransplant. The high infection and death rates are also concerning.

Impact of cyclosporine withdrawal on living related renal transplants: a single-center experience.

High treatment costs force the discontinuation of cyclosporine (CSA) in a vast majority of renal transplant recipients in India. The impact of CSA withdrawal among 108 living related renal transplant recipients 12.54 +/- 4.2 months after transplantation was studied retrospectively. In 83 patients, CSA was withdrawn over a 12-week period (group I). Azathioprine dosage was increased to 2 to 2.5 mg/kg/d, and prednisolone, to 30 mg/d 2 weeks and 1 week before starting CSA withdrawal, respectively. In the other 25 patients, CSA had to be withdrawn faster (mean, 28.52 +/- 14.18 days; group II). Twenty-nine rejection episodes (26.9%) were noted in 22 patients (20.4%; 19% in group I and 52% in group II; P: = 0.008). Fifteen group-I patients (18%) and 11 group-II patients (44%) died or lost their grafts (P: = 0.017). There was no difference in age, donor source, HLA matches, pretransplantation cross-match positivity, delayed graft function, immunosuppressive drug doses, rejection episodes, or prewithdrawal serum creatinine levels between the patients who did or did not develop acute rejection after CSA withdrawal. On follow-up, 10 patients (50%) died or returned to dialysis among the rejection group compared with 16 patients (18%) in the nonrejection group (P: = 0.007). The mean creatinine level at last follow-up was greater in the rejection group (3.97 +/- 2.54 versus 1.65 +/- 1.1 mg/dL; P: < 0.001). CSA withdrawal because of economic constraints carries a significant risk for acute rejection and death and/or graft loss in Indian living donor renal transplant recipients, even after 12 months.

The impact of early clinical training in medical education: a multi-institutional assessment.

With funding from The Robert Wood Johnson Foundation's Generalist Physician Initiative, Dartmouth Medical School (DMS), New York Medical College (NYMC), and Virginia Commonwealth University School of Medicine (VCU-SOM) adopted early community-based training models for longitudinal clinical experiences. These schools developed different evaluation strategies to assess these models. This paper describes each program, the method used to evaluate an aspect of the program, lessons learned about early clinical teaching and learning, and challenges encountered. Each program used cross-sectional evaluation, and the analysis methods included descriptive statistics, chi-square, t-tests, analysis of variance, and generalized linear models. Dartmouth determined that the type of preceptor does not greatly influence the development of clinical skills, although case-specific differences were discovered. NYMC learned that students taught clinical skills in community-based settings performed as well as or better than their peers who received early patient experience on hospital wards. Virginia Commonwealth discovered that community experiences contributed positively to students' education, critical thinking, and problem-solving skills. Students value early clinical experiences and make important achievements in clinical skills and knowledge development, although logistic challenges exist in conducting these courses. Evaluations are critical to ensure competency, and faculty development must be linked to the evaluation process.

Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.

To clarify the role of contrast-enhanced non-T1-weighted spin-echo (SE) MR imaging, phantom experiments and 20 clinical examinations were conducted. All of the SE pulse sequences demonstrated enhancement on gadopentetate dimeglumine solution phantoms. Enhancement effect was also observed on proton density-weighted and T2-weighted images in tumors. This property might be better recognized and utilized in selecting pulse sequences in routine MR examinations.

Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.

To clarify the enhancement pattern of gradient-echo (GE) MR imaging, phantom experiments and 24 clinical examinations of the head and neck region were performed. Both long repetition time (TR) GE and short TR GE pulse sequences demonstrated an enhancement pattern similar to T1-weighted spin-echo imaging in phantom experiments, although the signal intensity of water and gadopentetate dimeglumine (Gd) solution was higher and the signal intensity of fat was lower with the GE technique. In clinical examinations, contrast-enhanced GE imaging was beneficial for tumors within fatty tissue, and for tumors with calcification or other magnetic susceptibility difference.

Gd-DTPA-enhanced short repetition time and short inversion time inversion recovery magnetic resonance imaging. Experimental and clinical assessment.

To suppress both water and fat signal while retaining the high signal of Gd-DTPA enhancement, magnetic resonance imaging (MRI) of phantoms and 28 patients with mass lesions was done using short repetition time (TR) and short inversion time inversion recovery (STIR) sequences. Optimal STIR pulse sequences of 500 to 1000/80-100/20-30 (TR/TI/TE) were determined by an experimental study. In most instances, a signal bandwidth of +/- 8 kHz was used to increase the signal-to-noise ratio. The authors measured image contrast between lesions and adjacent fatty tissue and compared postcontrast STIR and T1-weighted spin-echo (T1-W SE) images. When the signal intensity of a lesion is 80% of adjacent fatty tissue on postcontrast T1-W SE, short TR STIR images provide better tumor delineation.